Global Health Limited Share Price & Analysis
₹1,148.5▲ +0.96%Updated 29 Apr 2026, 11:32 am IST
LTP
₹1,148.5
+0.96%
Open
₹—
High
₹1,171.45
Low
₹1,132.25
Close
₹1,148.5
52W High
₹1,456
52W Low
₹955
Volume
59K
Lot Size
1
Sector
Healthcare
Market Cap
₹30K Cr
Face Value
₹2
Large CapNIFTY 500
Price Chart
Fundamentals
P/E
52.5
Sector P/E
41.5
P/B
8.32
EPS
₹19.13
ROE
16.5%
ROCE
19.7%
D/E Ratio
0.25
Div Yield
0.05%
Book Value
₹138
+
Strengths
- ✓Strong return on equity (ROE 16.5%)
- ✓Efficient capital deployment (ROCE 19.7%)
- ✓Low debt relative to equity (D/E 0.3x)
−
Concerns
- ✗High premium to book value (P/B 8.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,779 | ₹3.9L Cr | 32 | 5.49 | 16.9 | 20.2 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,534 | ₹1.7L Cr | 66.7 | 11.25 | 15.4 | 20.4 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,232 | ₹1.4L Cr | 60.4 | 16.93 | 26.5 | 27 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹7,709 | ₹1.1L Cr | 61.2 | 12.2 | 18.4 | 16.6 | 0.88 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,330 | ₹1.1L Cr | 19.7 | 3.08 | 18 | 22.7 | 0.16 |
| LUPIN Lupin Limited | ₹2,311 | ₹1.0L Cr | 21.1 | 5.38 | 20.6 | 21.3 | 0.32 |
| CIPLA Cipla Limited | ₹1,318 | ₹1.0L Cr | 22 | 3.23 | 17.8 | 22.7 | 0.01 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
MEDANTA · as of Mar 2026
Promoters33.03%
FII11.76%▼0.72
DII11.93%▲1.42
Public43.28%▼0.70
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 33.05% | 33.04% | 33.04% | 33.04% | 33.03% | 33.03% |
| FII | 11.36% | 12.10% | 12.94% | 12.21% | 12.48% | 11.76% |
| DII | 11.15% | 10.25% | 10.57% | 11.11% | 10.51% | 11.93% |
| Public | 44.45% | 44.60% | 43.44% | 43.64% | 43.98% | 43.28% |
Corporate Events
Dividend - Re 0.50 Per Share
Dividend21 Aug 2025
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.1K Cr ▲2.0% | ₹1.1K Cr ▲6.6% | ₹1.0K Cr ▲10.7% | ₹931 Cr ▼1.3% | ₹943 Cr ▼1.5% | ₹957 Cr ▲11.1% | ₹861 Cr ▲6.4% | ₹809 Cr |
| Op. Profit | ₹217 Cr ▼6.1% | ₹231 Cr ▼6.5% | ₹247 Cr ▲9.8% | ₹225 Cr ▼5.5% | ₹238 Cr ▲4.4% | ₹228 Cr ▲22.6% | ₹186 Cr ▲3.9% | ₹179 Cr |
| OPM | 19.0% ▼9.5% | 21.0% ▼12.5% | 24.0% ▲0.0% | 24.0% ▼4.0% | 25.0% ▲4.2% | 24.0% ▲9.1% | 22.0% ▲0.0% | 22.0% |
| Net Profit | ₹95 Cr ▼39.9% | ₹158 Cr ▼0.6% | ₹159 Cr ▲57.4% | ₹101 Cr ▼29.4% | ₹143 Cr ▲9.2% | ₹131 Cr ▲23.6% | ₹106 Cr ▼16.5% | ₹127 Cr |
| EPS (₹) | 3.54 ▼39.9% | 5.89 ▼0.5% | 5.92 ▲56.6% | 3.78 ▼28.9% | 5.32 ▲9.2% | 4.87 ▲23.0% | 3.96 ▼16.5% | 4.74 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3.7K Cr ▲12.7% | ₹3.3K Cr ▲20.8% | ₹2.7K Cr ▲25.1% | ₹2.2K Cr ▲49.8% | ₹1.4K Cr ▼3.5% | ₹1.5K Cr ▲3.0% | ₹1.5K Cr ▲8.4% | ₹1.3K Cr ▼2.8% | ₹1.4K Cr |
| Expenses | ₹2.8K Cr ▲13.8% | ₹2.5K Cr ▲19.0% | ₹2.1K Cr ▲21.3% | ₹1.7K Cr ▲36.7% | ₹1.3K Cr ▼4.5% | ₹1.3K Cr ▲2.0% | ₹1.3K Cr ▲5.3% | ₹1.2K Cr ▲12.7% | ₹1.1K Cr |
| Op. Profit | ₹886 Cr ▲9.5% | ₹809 Cr ▲27.0% | ₹637 Cr ▲39.1% | ₹458 Cr ▲132.5% | ₹197 Cr ▲2.6% | ₹192 Cr ▲11.6% | ₹172 Cr ▲37.6% | ₹125 Cr ▼58.5% | ₹301 Cr |
| OPM | 24.0% ▼4.0% | 25.0% ▲4.2% | 24.0% ▲14.3% | 21.0% ▲50.0% | 14.0% ▲7.7% | 13.0% ▲8.3% | 12.0% ▲33.3% | 9.0% ▼59.1% | 22.0% |
| Other Income | ₹29 Cr ▼61.3% | ₹75 Cr ▲53.1% | ₹49 Cr ▲25.6% | ₹39 Cr ▲25.8% | ₹31 Cr ▼29.5% | ₹44 Cr ▼12.0% | ₹50 Cr ▲2.0% | ₹49 Cr ▲8.9% | ₹45 Cr |
| Interest | ₹74 Cr ▼11.9% | ₹84 Cr ▼2.3% | ₹86 Cr ▲0.0% | ₹86 Cr ▲17.8% | ₹73 Cr ▲28.1% | ₹57 Cr ▲50.0% | ₹38 Cr ▲35.7% | ₹28 Cr ▲100.0% | ₹14 Cr |
| Depreciation | ₹194 Cr ▲12.1% | ₹173 Cr ▲15.3% | ₹150 Cr ▲15.4% | ₹130 Cr ▲5.7% | ₹123 Cr ▲7.0% | ₹115 Cr ▲12.7% | ₹102 Cr ▲18.6% | ₹86 Cr ▲22.9% | ₹70 Cr |
| PBT | ₹647 Cr ▲3.2% | ₹627 Cr ▲39.6% | ₹449 Cr ▲59.8% | ₹281 Cr ▲778.1% | ₹32 Cr ▼50.0% | ₹64 Cr ▼22.9% | ₹83 Cr ▲38.3% | ₹60 Cr ▼77.1% | ₹262 Cr |
| Tax % | 26.0% ▲8.3% | 24.0% ▼11.1% | 27.0% ▼10.0% | 30.0% ▲172.7% | 11.0% ▼74.4% | 43.0% ▲13.2% | 38.0% ▼15.6% | 45.0% ▲28.6% | 35.0% |
| Net Profit | ₹481 Cr ▲0.6% | ₹478 Cr ▲46.6% | ₹326 Cr ▲66.3% | ₹196 Cr ▲575.9% | ₹29 Cr ▼19.4% | ₹36 Cr ▼29.4% | ₹51 Cr ▲54.5% | ₹33 Cr ▼80.6% | ₹170 Cr |
| EPS (₹) | 17.92 ▲0.6% | 17.81 ▲46.5% | 12.16 ▲56.9% | 7.75 ▲33.4% | 5.81 ▼21.1% | 7.36 ▼29.5% | 10.44 ▲54.0% | 6.78 ▼80.7% | 35.1 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹54 Cr ▲0.0% | ₹54 Cr ▲0.0% | ₹54 Cr ▲0.0% | ₹54 Cr ▲5.9% | ₹51 Cr ▲2.0% | ₹50 Cr ▲2.0% | ₹49 Cr ▲0.0% | ₹49 Cr ▲2.1% | ₹48 Cr ▲0.0% | ₹48 Cr |
| Reserves | ₹3.7K Cr ▲9.6% | ₹3.3K Cr ▲16.9% | ₹2.9K Cr ▲20.1% | ₹2.4K Cr ▲51.8% | ₹1.6K Cr ▲17.4% | ₹1.3K Cr ▲2.5% | ₹1.3K Cr ▲4.3% | ₹1.2K Cr ▲9.7% | ₹1.1K Cr ▲16.4% | ₹976 Cr |
| Borrowings | ₹945 Cr ▲31.6% | ₹718 Cr ▼10.5% | ₹802 Cr ▼28.5% | ₹1.1K Cr ▲1.2% | ₹1.1K Cr ▲19.1% | ₹931 Cr ▲0.2% | ₹929 Cr ▲18.0% | ₹787 Cr ▲72.6% | ₹456 Cr ▲176.4% | ₹165 Cr |
| Other Liabilities | ₹757 Cr ▲14.4% | ₹662 Cr ▲15.7% | ₹572 Cr ▲4.6% | ₹547 Cr ▲29.9% | ₹421 Cr ▲10.8% | ₹380 Cr ▼2.1% | ₹388 Cr ▲11.8% | ₹347 Cr ▲1.2% | ₹343 Cr ▲16.3% | ₹295 Cr |
| Total Liabilities | ₹5.4K Cr ▲13.5% | ₹4.8K Cr ▲11.4% | ₹4.3K Cr ▲4.5% | ₹4.1K Cr ▲30.2% | ₹3.1K Cr ▲16.8% | ₹2.7K Cr ▲1.1% | ₹2.7K Cr ▲9.7% | ₹2.4K Cr ▲22.5% | ₹2.0K Cr ▲33.6% | ₹1.5K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹3.2K Cr ▲27.2% | ₹2.5K Cr ▲12.4% | ₹2.2K Cr ▲9.1% | ₹2.0K Cr ▲15.4% | ₹1.8K Cr ▲9.9% | ₹1.6K Cr ▼5.1% | ₹1.7K Cr ▲42.6% | ₹1.2K Cr ▲9.1% | ₹1.1K Cr ▲19.7% | ₹914 Cr |
| CWIP | ₹318 Cr ▼40.3% | ₹533 Cr ▲37.4% | ₹388 Cr ▲18.7% | ₹327 Cr ▼25.5% | ₹439 Cr ▼5.4% | ₹464 Cr ▲21.5% | ₹382 Cr ▼42.6% | ₹666 Cr ▲110.1% | ₹317 Cr ▲2541.7% | ₹12 Cr |
| Investments | ₹3 Cr ▲0.0% | ₹3 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹1.9K Cr ▲10.1% | ₹1.7K Cr ▲3.6% | ₹1.7K Cr ▼3.7% | ₹1.7K Cr ▲84.9% | ₹930 Cr ▲51.2% | ₹615 Cr ▲5.9% | ₹581 Cr ▲1.9% | ₹570 Cr ▼0.5% | ₹573 Cr ▲2.5% | ₹559 Cr |
| Total Assets | ₹5.4K Cr ▲13.5% | ₹4.8K Cr ▲11.4% | ₹4.3K Cr ▲4.5% | ₹4.1K Cr ▲30.2% | ₹3.1K Cr ▲16.8% | ₹2.7K Cr ▲1.1% | ₹2.7K Cr ▲9.7% | ₹2.4K Cr ▲22.5% | ₹2.0K Cr ▲33.6% | ₹1.5K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹624 Cr ▲2.0% | ₹612 Cr ▼5.1% | ₹645 Cr ▲107.4% | ₹311 Cr ▲28.5% | ₹242 Cr ▲38.3% | ₹175 Cr ▲5.4% | ₹166 Cr ▲163.5% | ₹63 Cr ▼72.4% | ₹228 Cr |
| Investing CF | ₹-721 Cr ▼63.5% | ₹-441 Cr ▼28.9% | ₹-342 Cr ▲18.8% | ₹-421 Cr ▼76.2% | ₹-239 Cr ▼174.7% | ₹-87 Cr ▲65.1% | ₹-249 Cr ▼260.9% | ₹-69 Cr ▲71.4% | ₹-241 Cr |
| Financing CF | ₹-97 Cr ▲81.1% | ₹-514 Cr ▼248.6% | ₹346 Cr ▲116.3% | ₹160 Cr ▲297.5% | ₹-81 Cr ▼8000.0% | ₹-1 Cr ▼101.0% | ₹97 Cr ▲977.8% | ₹9 Cr ▲228.6% | ₹-7 Cr |
| Net Cash Flow | ₹-194 Cr ▲43.4% | ₹-343 Cr ▼152.9% | ₹648 Cr ▲1196.0% | ₹50 Cr ▲164.1% | ₹-78 Cr ▼189.7% | ₹87 Cr ▲521.4% | ₹14 Cr ▲366.7% | ₹3 Cr ▲115.0% | ₹-20 Cr |
| Free Cash Flow | ₹110 Cr ▼67.2% | ₹335 Cr ▼18.1% | ₹409 Cr ▲976.3% | ₹38 Cr ▼62.0% | ₹100 Cr ▲869.2% | ₹-13 Cr ▲90.2% | ₹-133 Cr ▼64.2% | ₹-81 Cr ▼214.1% | ₹71 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 29d ▲20.8% | 24d ▼7.7% | 26d ▼13.3% | 30d ▼11.8% | 34d ▼5.6% | 36d ▼12.2% | 41d ▲0.0% | 41d ▲105.0% | 20d |
| Inventory Days | 28d ▼12.5% | 32d ▼8.6% | 35d ▼2.8% | 36d ▼14.3% | 42d ▼2.3% | 43d ▲65.4% | 26d ▲0.0% | 26d ▼7.1% | 28d |
| Days Payable | 81d ▼10.0% | 90d ▼21.1% | 114d ▲26.7% | 90d ▼34.8% | 138d ▼6.1% | 147d ▲3.5% | 142d ▲14.5% | 124d ▲34.8% | 92d |
| Cash Conv. Cycle | -24d ▲29.4% | -34d ▲34.6% | -52d ▼116.7% | -24d ▲61.3% | -62d ▲7.5% | -67d ▲10.7% | -75d ▼33.9% | -56d ▼24.4% | -45d |
| Working Capital Days | -21d ▲34.4% | -32d ▲13.5% | -37d ▼85.0% | -20d ▲58.3% | -48d ▼54.8% | -31d ▼72.2% | -18d ▲45.5% | -33d ▼43.5% | -23d |
| ROCE | 20.0% ▲0.0% | 20.0% ▲17.6% | 17.0% ▲13.3% | 15.0% ▲200.0% | 5.0% ▼16.7% | 6.0% ▲0.0% | 6.0% | — | — |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Global Health Limited share price today?▾
Global Health Limited (MEDANTA) is currently trading at ₹1,148.5 on NSE, up 0.96% as of the last market session. Prices update daily after market close on MarketNetra.
Is Global Health Limited available in F&O (Futures & Options)?▾
Yes, Global Health Limited (MEDANTA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Global Health Limited 52-week high and low?▾
Global Health Limited's 52-week high is ₹1,456 and the 52-week low is ₹955. The current price of ₹1,148.5 is 21.1% below the 52W high.
What is Global Health Limited P/E ratio?▾
Global Health Limited's current P/E ratio is 52.5. This indicates the market is paying ₹52.5 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Global Health Limited options?▾
Global Health Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade MEDANTA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.